Skip to main content
. Author manuscript; available in PMC: 2019 Aug 19.
Published in final edited form as: Virology. 2013 Nov 21;449:25–34. doi: 10.1016/j.virol.2013.11.005

Table 2B.

EHV-1 genes display enhanced expression in the absence of the UL4 gene

Fold Increasea Avg Fold Increased
Gene Exp 1b Exp 2c Exp 3c SEMe Name Functionf HSV
ORF38 1.54 1.45 1.76 1.60 0.155 UL38 Thymidine kinase UL23
IR3 1.52 1.17 2.03 1.60 0.430 IR3 microRNA none
ORF39 1.67 1.41 1.78 1.60 0.185 UL39 gH UL22
ORF18 1.89 1.54 1.61 1.58 0.035 UL18 DNA process UL42
ORF45 1.59 1.42 1.73 1.57 0.155 UL45 Tegument req. for cleavage/packaging UL17
ORF74 1.33 1.45 1.59 1.52 0.070 US7 gE US8
ORF17 1.10 1.61 1.43 1.52 0.090 UL17 Membrane UL43
ORF46 1.93 1.38 1.63 1.50 0.125 UL46 Capsid-assoc. req. for cleavage/packaging UL16
ORF49 1.77 1.35 1.66 1.50 0.155 UL49 Tyr protein kinase UL13
ORF75 1.96 1.40 1.60 1.50 0.100 US8 “10K” none
ORF34 1.96 1.45 1.54 1.49 0.045 UL34 ?? none
ORF29 1.61 1.37 1.61 1.49 0.120 UL29 Req. for envelopment UL31
ORF50 1.69 1.38 1.59 1.49 0.105 UL50 Alkaline Dnase UL12
ORF28 1.56 1.35 1.59 1.47 0.120 UL28 Cleavage/packaging UL32
ORF8 1.34 1.32 1.61 1.47 0.145 UL8 Tegument UL51
ORF27 1.29 1.27 1.64 1.46 0.185 UL27 Packaging UL33
ORF24 1.53 1.37 1.54 1.46 0.085 UL24 ICP1/2 tegument UL36
ORF69 1.23 1.44 1.45 1.45 0.005 US2 Protein kinase US3
ORF25 2.18 1.27 1.61 1.44 0.170 UL25 Capsid UL35
ORF20 1.93 1.24 1.64 1.44 0.200 UL20 RR2 UL40
ORF7 1.19 1.27 1.56 1.42 0.145 UL7 Helicase/primase UL52
ORF26 1.66 1.30 1.52 1.41 0.110 UL26 Membrane UL34
ORF5 1.32 1.31 1.46 1.39 0.075 UL5 EICP27 UL54
ORF51 2.13 1.21 1.56 1.38 0.175 UL51 Virion and envelopment UL11
ORF31 1.57 1.36 1.40 1.38 0.020 UL31 ICP8 ssDNA-binding protein UL29
ORF48 1.22 1.17 1.58 1.38 0.205 UL48 Tegument UL14
ORF21 1.31 1.24 1.47 1.36 0.115 UL21 RR1 UL39
ORF67 1.91 1.35 1.36 1.36 0.005 IR6 Virion forms filaments none
IR4/UL3 1.31 1.18 1.45 1.32 0.135 Hybrid none
ORF32 1.09 1.19 1.30 1.24 0.055 UL32 Cleavage/packaging UL28
ORF64.1 0.74 0.95 1.50 1.23 0.275 IR1 IE ICP4
ORF76 0.94 1.14 1.29 1.22 0.075 US9 Tegument US9
ORF63 1.35 1.00 1.36 1.18 0.180 UL63 EICP0 IE110
ORF65 1.13 1.00 1.25 1.13 0.125 IR4 EICP22 US1
ORF1g −1.06 0.69 1.50 1.10 0.405 UL1 MHC-I downregulation, immune evasion UL56
Actin 0.80 1.01 1.00 1.00 0.005
GAPDH 1.00 1.00 1.00 1.00 0.000
ORF4h −0.10 0.17 0.38 0.27 0.105 UL4 Inhibitory protein req. for DIP generation UL55
a

Fold increase ΔUL4 EHV-1 vs. wild-type EHV-1. Data are from three independent experiments (Exp)

b

Infection MOI 5

c

Infection MOI 10

d

Average fold increase for Exps 2 & 3

e

Standard error from mean Exps 2 & 3

f

Function or location is assigned based on sequence analysis (Telford et al., 1992)

g

ORF1 deleted in both wild-type EHV-1 and ΔUL4 EHV-1

h

ORF4 deleted in ΔUL4 EHV-1 but present in wild-type EHV-1